FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility…
Submits Recalculated Initial Offer of $4.75 Based on Board’s Value Destructive ActionsNominated Two Independent Candidates to Restore Oversight and Protect…